{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:04:38Z","timestamp":1794895478369,"version":"4.9.1"},"reference-count":47,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1,19]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Standardized flow cytometry allows highly sensitive MRD measurements in virtually all BCP-ALL patients. If sufficient cells are measured (&gt;4 million), flow cytometric MRD analysis is at least as sensitive as current PCR-based MRD methods.<\/jats:p>","DOI":"10.1182\/blood-2016-07-726307","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T22:50:29Z","timestamp":1480546229000},"page":"347-357","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":415,"title":["Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"129","author":[{"given":"Prisca","family":"Theunissen","sequence":"first","affiliation":[{"name":"Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Mejstrikova","sequence":"additional","affiliation":[{"name":"Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Sedek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alita J.","family":"van der Sluijs-Gelling","sequence":"additional","affiliation":[{"name":"Dutch Childhood Oncology Group, The Hague, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gaipa","sequence":"additional","affiliation":[{"name":"Centro Ricerca Tettamanti, Clinica Pediatrica Universit\u00e0 di Milano Bicocca, Monza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Bartels","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Sobral da Costa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kotrov\u00e1","sequence":"additional","affiliation":[{"name":"Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Novakova","sequence":"additional","affiliation":[{"name":"Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic;"},{"name":"Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Sonneveld","sequence":"additional","affiliation":[{"name":"Dutch Childhood Oncology Group, The Hague, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Buracchi","sequence":"additional","affiliation":[{"name":"Centro Ricerca Tettamanti, Clinica Pediatrica Universit\u00e0 di Milano Bicocca, Monza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bonaccorso","sequence":"additional","affiliation":[{"name":"Centro Ricerca Tettamanti, Clinica Pediatrica Universit\u00e0 di Milano Bicocca, Monza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elen","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen G.","family":"te Marvelde","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Szczepanski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lhermitte","sequence":"additional","affiliation":[{"name":"Department of Hematology, H\u00f4pital Necker-Enfants-Malades and Unit\u00e9 Mixte de Recherche Centre National de la Recherche Scientifique 8147, University of Paris Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hrusak","sequence":"additional","affiliation":[{"name":"Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Lecrevisse","sequence":"additional","affiliation":[{"name":"Cancer Research Center (Instituto de Biolog\u00eda Molecular y Celular del Cancer\u2013Consejo Superior de Investigaciones Cient\u00edficas), Department of Medicine and Cytometry Service, University of Salamanca, Institute of Biomedical Research of Salamanca, Salamanca, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana Emilia","family":"Grigore","sequence":"additional","affiliation":[{"name":"Cytognos SL, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fro\u0148kov\u00e1","sequence":"additional","affiliation":[{"name":"Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Trka","sequence":"additional","affiliation":[{"name":"Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Br\u00fcggemann","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"Cancer Research Center (Instituto de Biolog\u00eda Molecular y Celular del Cancer\u2013Consejo Superior de Investigaciones Cient\u00edficas), Department of Medicine and Cytometry Service, University of Salamanca, Institute of Biomedical Research of Salamanca, Salamanca, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111903062419400_B1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/leu.2008.5","article-title":"Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia","volume":"22","author":"Flohr","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"2019111903062419400_B2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"2019111903062419400_B3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-59745-418-6_7","article-title":"MRD detection in acute lymphoblastic leukemia patients using Ig\/TCR gene rearrangements as targets for real-time quantitative PCR","volume":"538","author":"van der Velden","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"31","key":"2019111903062419400_B4","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1200\/JCO.2008.20.8934","article-title":"Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow","volume":"27","author":"Basso","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111903062419400_B5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood-2015-03-633685","article-title":"Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children\u2019s Oncology Group study AALL0232","volume":"126","author":"Borowitz","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2019111903062419400_B6","doi-asserted-by":"crossref","first-page":"e69467","DOI":"10.1371\/journal.pone.0069467","article-title":"Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"issue":"23","key":"2019111903062419400_B7","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1182\/blood-2009-11-253435","article-title":"Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia","volume":"115","author":"Stow","year":"2010","journal-title":"Blood"},{"key":"2019111903062419400_B8","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/bcj.2013.31","article-title":"Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia","volume":"3","author":"Weng","year":"2013","journal-title":"Blood Cancer J"},{"issue":"6","key":"2019111903062419400_B9","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","article-title":"Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia","volume":"99","author":"Dworzak","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111903062419400_B10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/leu.2012.231","article-title":"Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"27","author":"Denys","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2019111903062419400_B11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2008.07429.x","article-title":"Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches","volume":"144","author":"Ryan","year":"2009","journal-title":"Br J Haematol"},{"key":"2019111903062419400_B12","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3324\/haematol.2011.060426","article-title":"Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for for minimal residual disease detection in childhood acute lymphoblasticleukemia","volume":"97","author":"Gaipa","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"2019111903062419400_B13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.2010.08456.x","article-title":"Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry","volume":"152","author":"Th\u00f6rn","year":"2011","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111903062419400_B14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2014.116707","article-title":"Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia","volume":"100","author":"Karawajew","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"2019111903062419400_B15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1309\/AJCPOOJRAVUN75GD","article-title":"B-ALL minimal residual disease flow cytometry: an application of a novel method for optimization of a single-tube model","volume":"143","author":"Shaver","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"2019111903062419400_B16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/cyto.a.20638","article-title":"A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders","volume":"73A","author":"Pedreira","year":"2008","journal-title":"Cytometry A"},{"issue":"9","key":"2019111903062419400_B17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cyto.a.20608","article-title":"Generation of flow cytometry data files with a potentially infinite number of dimensions","volume":"73","author":"Pedreira","year":"2008","journal-title":"Cytometry A"},{"issue":"9","key":"2019111903062419400_B18","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"9","key":"2019111903062419400_B19","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"2019111903062419400_B20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2014.107706","article-title":"Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood","volume":"100","author":"Aalbers","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"2019111903062419400_B21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cyto.b.21228","article-title":"Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting","volume":"90","author":"Arroz","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"2019111903062419400_B22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.leu.2402475","article-title":"Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR","volume":"16","author":"van der Velden","year":"2002","journal-title":"Leukemia"},{"issue":"7","key":"2019111903062419400_B23","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/sj.leu.2402515","article-title":"T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis","volume":"16","author":"van der Velden","year":"2002","journal-title":"Leukemia"},{"issue":"5","key":"2019111903062419400_B24","first-page":"679","article-title":"Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease","volume":"91","author":"van der Velden","year":"2006","journal-title":"Haematologica"},{"issue":"10","key":"2019111903062419400_B25","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood-2003-08-2952","article-title":"Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells","volume":"103","author":"Szczepanski","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111903062419400_B26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.leu.2403263","article-title":"Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia","volume":"18","author":"Br\u00fcggemann","year":"2004","journal-title":"Leukemia"},{"issue":"8","key":"2019111903062419400_B27","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood-2015-07-655159","article-title":"The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL","volume":"126","author":"Kotrova","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2019111903062419400_B28","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.leu.2402150","article-title":"BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted action investigation of minimal residual disease in acute leukemia: international standardization and clinical evaluation","volume":"15","author":"Lucio","year":"2001","journal-title":"Leukemia"},{"issue":"3","key":"2019111903062419400_B29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.leu.2401279","article-title":"Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL","volume":"13","author":"L\u00facio","year":"1999","journal-title":"Leukemia"},{"issue":"1","key":"2019111903062419400_B30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/pbc.22261","article-title":"Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry","volume":"54","author":"Mejstr\u00edkov\u00e1","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"2019111903062419400_B31","first-page":"1245","article-title":"Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia","volume":"88","author":"Veltroni","year":"2003","journal-title":"Haematologica"},{"issue":"23","key":"2019111903062419400_B32","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","article-title":"New markers for minimal residual disease detection in acute lymphoblastic leukemia","volume":"117","author":"Coustan-Smith","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111903062419400_B33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cyto.a.21162","article-title":"CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry","volume":"81","author":"Solly","year":"2012","journal-title":"Cytometry A"},{"issue":"8","key":"2019111903062419400_B34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.leukres.2011.03.028","article-title":"High expression of cytoskeletal protein drebrin in TEL\/AML1pos B-cell precursor acute lymphoblastic leukemia identified by a novel monoclonal antibody","volume":"35","author":"Vaskova","year":"2011","journal-title":"Leuk Res"},{"issue":"5","key":"2019111903062419400_B35","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/sj.leu.2403706","article-title":"Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia","volume":"19","author":"Vaskova","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"2019111903062419400_B36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3109\/10428194.2015.1070153","article-title":"The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia","volume":"57","author":"Wang","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"26","key":"2019111903062419400_B37","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2015-03-580027","article-title":"Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies","volume":"125","author":"van Dongen","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2019111903062419400_B38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.V87.3.1134.bloodjournal8731134","article-title":"Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements","volume":"87","author":"Behm","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2019111903062419400_B39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.leu.2404578","article-title":"Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement","volume":"21","author":"Jansen","year":"2007","journal-title":"Leukemia"},{"key":"2019111903062419400_B40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2407-5-38","article-title":"Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens","volume":"5","author":"Kalina","year":"2005","journal-title":"BMC Cancer"},{"issue":"1","key":"2019111903062419400_B41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.leukres.2013.10.008","article-title":"Significance of CD66c expression in childhood acute lymphoblastic leukemia","volume":"38","author":"Kiyokawa","year":"2014","journal-title":"Leuk Res"},{"issue":"7","key":"2019111903062419400_B42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3324\/haematol.2008.000299","article-title":"Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia","volume":"94","author":"Djokic","year":"2009","journal-title":"Haematologica"},{"key":"2019111903062419400_B43","article-title":"A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia\/lymphoma post anti-CD19 therapy","author":"Cherian","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"2019111903062419400_B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20008","article-title":"Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts","volume":"60","author":"van Lochem","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"2019111903062419400_B45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cyto.b.21239","article-title":"Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry","volume":"90","author":"Wood","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"2019111903062419400_B46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/bmt.2008.122","article-title":"B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL","volume":"42","author":"Fronkova","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111903062419400_B47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.leu.2404925","article-title":"Non-specific amplification of patient-specific Ig\/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring","volume":"22","author":"van der Velden","year":"2008","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/3\/347\/1401474\/blood726307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/3\/347\/1401474\/blood726307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:06:48Z","timestamp":1574132808000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/3\/347\/36021\/Standardized-flow-cytometry-for-highly-sensitive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,1,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-07-726307","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}